Some of Thursday's midday movers:» Read More
Becton, Dickinson& Co. rose $2.32 or 1.6 percent, to $145.17. Covidien plc rose $4.00 or 3.9 percent, to $106.45. Thermo Fisher Scientific Inc. rose $1.64 or 1.3 percent, to $127.00.
Becton, Dickinson& Co. rose $1.96 or 1.4 percent, to $144.81. Covidien plc rose $3.62 or 3.5 percent, to $106.07. PerkinElmer rose$. 23 or. 5 percent, to $43.62.
Covidien plc rose $2.55 or 2.5 percent, to $105.00. PerkinElmer fell$. 08 or. 2 percent, to $43.31. Thermo Fisher Scientific Inc. rose$. 64 or. 5 percent, to $126.00.
Becton, Dickinson& Co. rose $2.57 or 1.8 percent, to $142.85. Covidien plc fell$. 93 or. 9 percent, to $102.45. PerkinElmer rose$. 36 or. 8 percent, to $43.39.
Becton, Dickinson& Co. rose $2.02 or 1.4 percent, to $142.30. Covidien plc rose$. 70 or. 7 percent, to $104.08. PerkinElmer rose$. 44 or 1.0 percent, to $43.47.
Becton, Dickinson& Co. rose $1.64 or 1.2 percent, to $141.92. Covidien plc rose$. 37 or. 4 percent, to $103.75. PerkinElmer rose$. 10 or. 2 percent, to $43.13.
Becton, Dickinson& Co. fell$. 10 or. 1 percent, to $140.28. Covidien fell$. 67 or. 6 percent, to $103.38. PerkinElmer fell$. 34 or. 8 percent, to $43.03.
Becton, Dickinson& Co. fell$. 48 or. 3 percent, to $139.90. Covidien plc fell$. 69 or. 7 percent, to $103.36. PerkinElmer fell$. 56 or 1.3 percent, to $42.82.
Becton, Dickinson& Co. fell$. 55 or. 4 percent, to $139.83. Covidien plc fell$. 38 or. 4 percent, to $103.67. PerkinElmer fell$. 49 or 1.1 percent, to $42.88.
LONDON, Nov 3- Thermo Fisher Scientific has pledged to correct a glitch in software used to analyse data from clinical drug trials within "four to eight weeks", after independent experts highlighted a potential for errors. "We are currently implementing a software update and will be performing rigorous testing to ensure that this issue is resolved," Sanjay...
*EU agency looking into issue with Thermo Fisher software. *Thermo Fisher says reviewing matter, no further comment. An official at the London- based European Medicines Agency told Reuters that the issue, involving Thermo Fisher Scientific's Kinetica package, would be discussed by European regulators at a meeting next week.
NEW YORK, Sept 29- U.S. securities regulators can move forward with a lawsuit accusing two Dubai residents of making $3.7 million through insider trading in Onyx Pharmaceuticals Inc and another biotechnology company, a Manhattan federal judge ruled on Monday.
FRANKFURT, Sept 22- Drugs and chemicals maker Merck KGaA agreed on Monday to acquire U.S.-based Sigma-Aldrich Corp for $17 billion in cash to boost its lab supplies business, the biggest takeover in the German group's history.
Sept 17- Laboratory equipment supplier VWR Corp said it expects its initial public offering of common stock to be priced between $22 and $25 per share, raising up to $638 million.
Some of the names on the move ahead of the open.
Cramer loves stock ideas. And he found more than his fair share at CNBC’s “Delivering Alpha” conference on Wednesday.
Billionaire investor Leon Cooperman gave 12 stock recommendations at the Delivering Alpha conference Wednesday.
Larry Robbins' big idea for companies is debt—loads of debt at a time when rates are still low but ready to rise.
Some of 2014's biggest winners are slated to share their next big ideas at this year's Delivering Alpha Conference.
Some of Thursday's midday movers: